Effects of losartan and enalapril on small artery structure in hypertensive rats

Hypertension

Volumn 32, Issue 2, 1998, Pages 305-310

  Rizzoni, Damiano ^a   Porteri, Enzo ^a   Piccoli, Alfonso ^a   Castellano, Maurizio ^a   Bettoni, Giorgio ^a   Muiesan, Maria Lorenza ^a   Pasini, Giancarlo ^a   Guelfi, Daniele ^a   Mulvany, Michael J ^b   Agabiti Rosei, Enrico ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

Angiotensin II; Angiotensin converting enzyme inhibitors; Enalapril; Hypertrophy; Losartan; Vascular resistance

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; LOSARTAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY DIAMETER; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; ESSENTIAL HYPERTENSION; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RESISTANCE BLOOD VESSEL; SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE;

EID: 0031843825     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.32.2.305     Document Type: Article

References (42)

1. Schelling P, Fischer H, Ganten D. Angiotensin and cell growth: a link to cardiovascular hypertrophy? J Hypertens. 1991;9:3-15.
2. Mulvany MJ. Resistance vessel growth and remodelling: cause or consequence in cardiovascular disease. J Hum Hypertens. 1995;9:479-485.
3. Schiffrin EL, Deng LY, Larochelle P. Effects of a β-blocker or a converting enzyme inhibitor on resistance arteries in essential hypertension. Hypertension. 1994;23:83-91.
4. Thybo NK, Stephens N, Cooper A, Aalkjaer C. Heagerty AM, Mulvany MJ. Effect of antihypertensive treatment on small arteries of patients with previously untreated essential hypertension. Hypertension. 1995;25(pt 1):474-481.
5. Rizzoni D, Muiesan ML, Porteri E, Castellano M, Zulli G, Bettoni G, Salvetti M, Monteduro C, Agabiti-Rosei E. Effect of long-term antihypertensive treatment with lisinopril on resistance arteries in hypertensive patients with left ventricular hypertrophy. J Hypertens. 1997;15:197-204.
6. Rizzoni D,. Castellano M, Porteri E, Bettoni G, Muiesan ML, Cinelli A, Agabiti-Rosei E. Effects of low and high doses of fosinopril on the structure and function of resistance arteries. Hypertension. 1995;26: 118-123.
7. Christensen KL, Jespersen LT, Mulvany MJ. Development of blood pressure in spontaneously hypertensive rats after withdrawal of long-term treatment related to vascular structure. J Hypertens. 1989;7:83-90.
8. Harrap SB, Van der Merwe WM, Griffin SA, MacPherson F, Lever AF. Brief angiotensin converting enzyme inhibitor treatment in young spontaneously hypertensive rats reduces blood pressure long term. Hypertension. 1990;16:603-614.
9. Adams MA, Bobik A, Korner PI. Enalapril can prevent vascular amplifier development in spontaneously hypertensive rats. Hypertension. 1990;16: 252-260.
10. Rizzoni D, Castellano M, Porteri E, Bettoni G, Muiesan ML, Cinelli A, Zulli R, Agabiti-Rosei E. Prolonged effects of short-term fosinopril on blood pressure and vascular morphology and function in rats. Am J Hypertens. 1997;10:1034-1043.
11. Gibbons GH. Angiotensin-converting enzyme inhibition and vascular structure in hypertension. J Cardiovasc Pharmacol. 1991;18(suppl 7):S19-S24.
12. Timmermans PBMWM, Smith RD. Angiotensin II receptor subtypes: selective antagonists and functional correlates. Eur Heart J. 1994;(suppl D):79-87.
13. Kaneko K, Susie D, Nunez E, Frohlich ED. Losartan reduces cardiac mass and improves coronary flow reserve in the spontaneously hypertensive rat. J Hypertens. 1996;14:645-653.
14. Gohlke P, Linz W, Schölkens A, Wiemer G, Unger T. Cardiac and vascular effects of long-term losartan treatment in stroke-prone spontaneously hypertensive rats. Hypertension. 1996;28:397-402.
15. Li JS, Sharafi AM, Schiffrin EL. Effect of ATI angiotensin-receptor blockade on structure and function of small resistance arteries in SHR. J Cardiovasc Pharmacol. 1997;30:75-83.
16. Morton JJ, Beattie EC, MacPherson F. Angiotensin II receptor antagonists losartan has persistent effect on blood pressure in the young spontaneously hypertensive rat: lack of relation to vascular structure. J Vasc Res. 1992;29:264-269.
17. Shaw LM, George PR, Oldham AA, Heagerty AM. A comparison of the effect of angiotensin converting enzyme inhibition and angiotensin II receptor antagonism on structural changes associated with hypertension in rat small arteries. J Hypertens. 1995;13:1135-1143.
18. Unger T, Chung O, Csikos T, Culman J, Gallinat S, Gohlke P, Höhle S, Meffert S, Stöll M, Stroth U, Zhu YZ. Angiotensin receptors. J Hypertens. 1996;14(suppl 5):S95-S103.
19. Yamada T, Horiuchi M, Dzau VJ. Angiotensin II type 2 receptor mediates programmed cell death. Proc Natl Acad Sci U S A. 1996;93:156-160.
20. Ledingham JM, Laverty R. Remodelling of resistance arteries in genetically hypertensive rats by treatment with valsartan, an angiotensin II receptor antagonists. Clin Exp Pharmacol Physiol. 1996;23:576-578.
21. Heagerty AM, Aalkjaaer C, Bund SJ, Korsgaard N, Mulvany MJ. Small artery structure in hypertension: dual process of remodeling and growth. Hypertension. 1993;21:391-397.
22. Mulvany MJ, Halpern W. Contractile properties of small resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res. 1977;41:19-26.
23. Mulvany MJ, Hansen PK, Aalkjaer C. Direct evidence that the greater contractility of resistance vessels in spontaneously hypertensive rats is associated with a narrowed lumen, a thickened media, and an increased number of smooth muscle cell layers. Circ Res. 1978;43:854-864.
24. Rizzoni D, Castellano M, Porteri E, Bettoni G, Muiesan ML, Agabiti-Rosei E. Vascular structural and functional alterations before and after the development of hypertension in SHR. Am J Hypertens. 1994;7: 193-200.
25. Rizzoni D, Castellano M, Porteri E, Bettoni G, Muiesan ML, Agabiti-Rosei E. Delayed development of hypertension after short-term nitrendipine treatment. Hypertension. 1994;24:131-139.
26. Baumbach GL, Heistad DD. Remodeling of cerebral arterioles in chronic hypertension. Hypertension. 1989;13:968-972.
27. Mulvany MJ, Baandrup U, Gundersen HJG. Evidence for hyperplasia in mesenteric resistance vessels of spontaneously hypertensive rats using a three-dimensional disector. Circ Res. 1985;57:794-800.
28. Korsgaard N, Mulvany MJ. Cellular hypertrophy in mesenteric resistance vessels from renal hypertensive rats. Hypertension. 1988;12:162-167.
29. Aalkjaer C, Heagerty AM, Petersen KK, Swales JD, Mulvany MJ. Evidence for increased media thickness, increased neural amine uptake, and depressed excitation-contraction coupling in isolated resistance vessels from essential hypertensives. Circ Res. 1987;61:181-186.
30. Korsgaard N, Aalkjaer C, Heageny AM. Izzard AS, Mulvany MJ. Histology of subcutaneous small arteries from patients with essential hypertension. Hypertension. 1993;22:523-526.
31. Lundie MJ, Friberg P, Line RL, Adams MA. Long-term inhibition of the renin-angiotensin system in genetic hypertension: analysis of the impact on blood pressure and cardiovascular structural changes. J Hypertens. 1997;15:339-348.
32. Kabour A, Henegar JR, Devinemi VR, Janicki JS. Prevention of angiotensin II-induced myocyte necrosis and coronary vascular damage by lisinopril and losartan in the rat. Cardiovasc Res. 1995;29:543-548.
33. Fornes P, Richer C, Vacher E, Bruneval P, Giudicelli JF. Losartan's protective effects in stroke-prone spontaneously hypertensive rats persists durably after treatment withdrawal. J Cardiovasc Pharmacol. 1993;22: 305-313.
34. Vacher E, Fornes P, Richer C, Bruneval P, Nisato D, Giudicelli JF. Early and late haemodynamic and morphological effects of angiotensin II subtype 1 receptor blockade during genetic hypertension development. J Hypertens. 1995;13:675-682.
35. Vacher E, Richer C, Giudicelli JF. Effect of losartan on cerebral arteries in stroke-prone spontaneously hypertensive rats. J Hypertens. 1996;14: 1341-1348.
36. Baandrup U, Gundersen HJG, Mulvany MJ. It is possible to solve the problem: hypertrophy/hyperplasia of smooth muscle cells in the vessel wall of hypertensive subjects? Prog Appl Microcirc. 1985;8:122-128.
37. Mulvany MJ, Baumbach GL, Aalkjaer C, Heagerty AM. Vascular remodeling. Hypertension. 1996;28:505-506. Letter.
38. Baker KM, Chemin MI, Wixson SK, Aceto JF. Renin-angiotensin system involvement in pressure-overload cardiac hypertrophy in rats. Am J Physiol. 1990;259:H324-H332.
39. Thybo NK, Korsgaard N, Eriksen S, Christensen KL, Mulvany MJ. Dose-dependent effects of perindopril on blood pressure and small artery structure. Hypertension. 1994;23:659-666.
40. Griffin SA, Brown WCB, MacPherson F, McGrath JC, Wilson VG, Korsgaard N, Mulvany MJ, Lever AF. Angiotensin II causes vascular hypertrophy in part by a non-pressor mechanism. Hypertension. 1991;17: 626-635.
41. Black MJ, Bertram JF, Campbell JH, Campbell GR. Angiotensin II induces cardiovascular hypertrophy in perindopril-treated rats. J Hypertens. 1995;13:683-692.
42. Korsgaard N, Christensen KL, Mulvany MJ. Cellular morphology in mesenteric resistance vessels from antihypertensive treated spontaneously hypertensive rats. In: Smits JFM, ed. Pharmacology of Cardiac and Vascular Remodelling. Darmstadt, Germany: Steinkopff Verlag; 1991:33-41.